Web Analytics

3 Latest Announced Rounds

  • $50,000,000
    Unknown

    4 Investors

    Hospital & Health Care
    Jul 2nd, 2024
  • $1,600,000
    Unknown

    1 Investors

    Retail Apparel and Fashion
    Jul 2nd, 2024
  • $13,500,000
    Series A

    3 Investors

    Technology, Information and Internet
    Jul 2nd, 2024
$2,110.02M Raised in 92 Funding Rounds in the past 7 Days - View All

Funding Round Profile

The Rounds (Canada)

start up
Canada - Halifax, NS
  • 14/02/2023
  • Series A
  • $6,700,000

The Rounds is the secure collaboration network modern healthcare professionals trust to improve healthcare outcomes. Physicians and HCPs join The Rounds to connect with peers and experts across therapeutic areas in a secure environment.

Business at The Rounds:
The Rounds provides a free platform for all healthcare professionals by generating revenue from the life sciences industry which strives to reach medical decision-makers with relevant product information. Since its creation in 2012, The Rounds has positioned itself as a Canadian market leader and forged industry relationships with national governing bodies including the Pharmaceutical Advertising Advisory Board (PAAB) and Innovative Medicines Canada (IMC).


Related People

Tim RiceFounder

Tim Rice Canada - Halifax, Nova Scotia

Tim Rice, CEO of The Rounds, is a recognized leader in the Life Sciences sector and devotes his time modernizing how physicians consume and share crucial information. Tim leads a passionate team driven by the mantra that sharing knowledge saves lives.

Through his role, Tim focuses on establishing a sustainable and scalable business model for the organization, helping the company's rapid growth while positively impacting the community. With over 20 years of experience in the healthcare industry, Tim has developed advanced skills in sales, medical education, marketing, and leadership roles.

Tim Rice is known to his colleagues and partners as a confident, personable, and dynamic individual who develops strong relationships.